Search Page

1

Cite

Share

Mast cells in neoangiogenesis.

Nienartowicz A, Sobaniec-Łotowska ME, Jarocka-Cyrta E, Lemancewicz D. Nienartowicz A, et al. Among authors: lemancewicz d. Med Sci Monit. 2006 Mar;12(3):RA53-6. Epub 2006 Feb 23. Med Sci Monit. 2006. PMID: 16501434 Review.

Cite

Share

2

Cite

Share

High immunoproteasome concentration in the plasma of patients with newly diagnosed multiple myeloma treated with bortezomib is predictive of longer OS.

Breczko W, Lemancewicz D, Dzięcioł J, Kłoczko J, Bołkun Ł. Breczko W, et al. Among authors: lemancewicz d. Adv Med Sci. 2020 Nov 24;66(1):21-27. doi: 10.1016/j.advms.2020.11.003. Online ahead of print. Adv Med Sci. 2020. PMID: 33246214

Cite

Share

3

Cite

Share

Angiogenesis in gliomas.

Lebelt A, Dziecioł J, Guzińska-Ustymowicz K, Lemancewicz D, Zimnoch L, Czykier E. Lebelt A, et al. Among authors: lemancewicz d. Folia Histochem Cytobiol. 2008;46(1):69-72. doi: 10.2478/v10042-008-0009-4. Folia Histochem Cytobiol. 2008. PMID: 18296266 Free article.

Cite

Share

4

Cite

Share

The levels of sMUC-1 in patients with multiple myeloma.

Lemancewicz D, Bolkun L, Porowska H, Galar M, Semeniuk J, Kloczko J, Dziecioł J. Lemancewicz D, et al. Folia Histochem Cytobiol. 2011;49(4):654-8. doi: 10.5603/fhc.2011.0089. Folia Histochem Cytobiol. 2011. PMID: 22252760 Free article.

Cite

Share

5

Cite

Share

The role of Interleukin-17A and Interleukin-17E in multiple myeloma patients.

Lemancewicz D, Bolkun L, Jablonska E, Czeczuga-Semeniuk E, Kostur A, Kloczko J, Dzieciol J. Lemancewicz D, et al. Med Sci Monit. 2012 Jan;18(1):BR54-59. doi: 10.12659/msm.882204. Med Sci Monit. 2012. PMID: 22207110 Free PMC article.

Cite

Share

6

Cite

Share

Prognostic significance of ligands belonging to tumour necrosis factor superfamily in acute lymphoblastic leukaemia.

Bolkun L, Lemancewicz D, Jablonska E, Szumowska A, Bolkun-Skornicka U, Moniuszko M, Dzieciol J, Kloczko J. Bolkun L, et al. Among authors: lemancewicz d. Leuk Res. 2015 Mar;39(3):290-5. doi: 10.1016/j.leukres.2014.12.012. Epub 2014 Dec 27. Leuk Res. 2015. PMID: 25582383

Cite

Share

7

Cite

Share

Differences and similarities between LC-MS derived serum fingerprints of patients with B-cell malignancies.

Piszcz J, Lemancewicz D, Dudzik D, Ciborowski M. Piszcz J, et al. Among authors: lemancewicz d. Electrophoresis. 2013 Oct;34(19):2857-64. Electrophoresis. 2013. PMID: 24228264

Cite

Share

8

Cite

Share

Evaluation of TNF superfamily molecules in multiple myeloma patients: correlation with biological and clinical features.

Lemancewicz D, Bolkun L, Jablonska E, Kulczynska A, Bolkun-Skornicka U, Kloczko J, Dzieciol J. Lemancewicz D, et al. Leuk Res. 2013 Sep;37(9):1089-93. doi: 10.1016/j.leukres.2013.05.014. Epub 2013 Jun 12. Leuk Res. 2013. PMID: 23768867

Cite

Share

9

Cite

Share

Bone marrow megakaryocytes, soluble P-selectin and thrombopoietic cytokines in multiple myeloma patients.

Lemancewicz D, Bolkun L, Mantur M, Semeniuk J, Kloczko J, Dzieciol J. Lemancewicz D, et al. Platelets. 2014;25(3):181-7. doi: 10.3109/09537104.2013.805405. Epub 2013 Jul 15. Platelets. 2014. PMID: 23855381

Cite

Share

10

Cite

Share

BAFF and APRIL as TNF superfamily molecules and angiogenesis parallel progression of human multiple myeloma.

Bolkun L, Lemancewicz D, Jablonska E, Kulczynska A, Bolkun-Skornicka U, Kloczko J, Dzieciol J. Bolkun L, et al. Among authors: lemancewicz d. Ann Hematol. 2014 Apr;93(4):635-44. doi: 10.1007/s00277-013-1924-9. Epub 2013 Oct 19. Ann Hematol. 2014. PMID: 24141333 Free PMC article.

Cite

Share